The prognosis biomarkers based on m6A-related lncRNAs for myeloid leukemia patients

The prognosis biomarkers based on m6A-related lncRNAs for myeloid leukemia patients

Abstract Background Chronic myeloid leukemia (CML) and acute myeloid leukemia (AML) are two common malignant disorders in leukemia. Although potent drugs are emerging, CML and AML may still relapse after the drug treatment is stopped. N6-methyladenosine (m6A) and lncRNAs play certain roles in the oc...

Full description

Bibliographic Details
Main Authors: Li-Rong Yang, Zhu-Ying Lin, Qing-Gang Hao, Tian-Tian Li, Yun Zhu, Zhao-Wei Teng, Jun Zhang
Format: Article
Language:English
Published: BMC 2022-01-01
Series:Cancer Cell International
Subjects:
m6A
m6A-related lncRNAs
CRNDE
CHROMR
NARF-IT1
Myeloid leukemia
Online Access:https://doi.org/10.1186/s12935-021-02428-3

Internet

https://doi.org/10.1186/s12935-021-02428-3

Similar Items